论文部分内容阅读
目的:对孟鲁司特钠口服加舒利迭吸入吸入治疗重度哮喘的疗效进行观察研究。方法:抽取2012年7月~2014年7月本院接诊的136例重度哮喘患者作为研究对象,按照抽签法将其分为观察组与对照组,每组各68例,对照组予以使用舒利迭吸入治疗,对观察组患者予以孟鲁斯特钠片口服加舒利迭吸入治疗,观察并比较两组患者临床疗效及不良反应。结果:治疗前两组患者临床症状评分无显著性差异(P>0.05),治疗后观察组低于对照组,组间比较差异具有统计学意义(P<0.05)。结论:孟鲁斯特钠口服加舒利迭吸入的治疗方法能够迅速改善患者肺功能,显示出其治疗的良好效果,具有确切疗效,且使用方便,患者依从性好,安全性极高,可以有效提高患者生活质量。
OBJECTIVE: To observe the effect of inhaled montelukast sodium oral inhaled seretide inhalation on severe asthma. Methods: Thirty-six patients with severe asthma admitted to our hospital from July 2012 to July 2014 were selected as the study subjects. According to the drawing method, they were divided into observation group and control group, with 68 cases in each group and the control group Diego inhalation therapy, patients in the observation group were treated with Montelukast sodium and sesquisilide inhalation therapy, the clinical efficacy and adverse reactions were observed and compared between the two groups. Results: There was no significant difference in clinical symptom scores between the two groups before treatment (P> 0.05). After treatment, the observation group was lower than that of the control group. The difference between the two groups was statistically significant (P <0.05). CONCLUSIONS: Montelukast sodium oral administration of seretide inhalation therapy can rapidly improve pulmonary function in patients, showing its good effect of treatment, with the exact effect, and easy to use, patients with good compliance, high security, you can Effectively improve the quality of life of patients.